MoneyWorks4Me

The sales for the September 2022 quarter moved down to Rs. 2580.00 millions as compared to Rs. 3100.00 millions during the year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -750.00 millions as compared to Net Loss of Rs. -640.00 millions of corresponding quarter ended September 2021Operating profit for the quarter ended September 2022 rose to 400.00 millions as compared to 130.00 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 2580.00 3100.00 -16.77 4990.00 5890.00 -15.28 13720.00 9870.00 39.01
Other Income 290.00 40.00 625.00 780.00 190.00 310.53 380.00 410.00 -7.32
PBIDT 400.00 130.00 207.69 940.00 320.00 193.75 2600.00 -970.00 -368.04
Interest 580.00 600.00 -3.33 1190.00 1150.00 3.48 2730.00 2000.00 36.50
PBDT -680.00 -470.00 44.68 -750.00 -830.00 -9.64 -130.00 -4390.00 -97.04
Depreciation 470.00 430.00 9.30 940.00 850.00 10.59 1710.00 1840.00 -7.07
PBT -1150.00 -900.00 27.78 -1690.00 -1680.00 0.60 -1840.00 -6230.00 -70.47
TAX -400.00 -260.00 53.85 -570.00 -550.00 3.64 -440.00 -2310.00 -80.95
Deferred Tax -400.00 -260.00 53.85 -570.00 -550.00 3.64 -490.00 -950.00 -48.42
PAT -750.00 -640.00 17.19 -1120.00 -1130.00 -0.88 -1400.00 -3920.00 -64.29
Equity 720.00 550.00 30.91 720.00 550.00 30.91 720.00 550.00 30.91
PBIDTM(%) 15.50 4.19 269.70 18.84 5.43 246.73 18.95 -9.83 -292.82
Peers
Company Name CMP
Sun Pharma. Inds. 1791.75
Dr. Reddys Labs. 1199.50
Cipla 1333.45
Lupin 2015.00
Zydus Lifesciences 1145.00
View more..